The primary targets identified were EGFR, MAPK1, MAPK14, AKT1, CASP3, and PRKACA, and ginseng and its constituents may have therapeutic promise for Alzheimer's disease. This evidence concerns the gene MAPK1 and early-onset autosomal dominant Alzheimer disease.